Navigation Links
Biocon to colloborate for development of Oral peptide drugs for heart diseases.

The Indian Biotech Company, Biocon to colloborate with Nobex Corporation of United States to develop a new oral peptide drug for cardiovascular diseases. The spokesperson of Biocon informed that the company has gone into global research collaboration // on Tuesday for development of peptide based product for treatment of cardiovasculoar diseases. The Biocon press release said, “The collaboration combines the peptide production capabilities of Biocon with the proprietary oral peptide deliver technology of Nobex. Biocon and Nobex plan to advance the oral human brain type natriuretic peptide (hBNP) program towards an Investigational New drug filing with the US food and Drug Administration in 2007 and clinical trials beginning later that year.

“Administration of hBNP by continuous infusion was approved by the FDA in August 200 for the treatment of acute congestive heart failure in the hospital care setting. The intent of an oral hBNP would be to have a product available for chronic use, rather than only for acute use for a number of potential indications, including early stage heart failure patients.’ It said.

“By co-developing a therapeutic product such a oral hBNP of substantial clinical and market value in treating heart failure and other potential cardiovascular indications, we are taking another step towards our innovative product development strategy,” the release quoted Ms Kiran Mazumdar-Shaw, chairman and managing director of Biocon, as sayin.
'"/>




Page: 1

Related medicine news :

1. Biocon To Raise Its Investment In Scotland
2. Biocon To Shift Focus On Innovation To Accelerate Growth
3. Kalam Dedicates New Cancer Drug Developed By Biocon
4. Bayer to Market Biocon Insulin in China
5. Biocon Launches Anti-Cancer Drug
6. Biocon to Launch Anti-arthritis Drug
7. Biocon Unveils Renal Therapies for Kidney Disorders
8. Biocon Net Profit Up by 15 Percent for Fiscal Year
9. Cancer drugs in development nearly doubled since 1995
10. Role of zinc in development
11. Particulate matter affects lung development
Post Your Comments:
(Date:10/8/2008)... HIV-test-kit.com is a new site aimed a....V. from the comfort and privacy of their own home... issue. It is hoped that through home tests more p...he AIDS virus. , New York...eople are getting more used to getting instant res...
(Date:10/8/2008)... Drug Information Association (DIA) wil...-7; Ottawa, Ontario, Canada) to discuss a number o...aceutical industry, health academia, and the healt... PA (PRWEB) October 8, 2008 -- The http://www.diah... host the http://www.diahome.org/diahome/FlagshipM...
(Date:10/8/2008)... AccurateAnswers™ support program...es for http://www.appointment-plus.com [online s... Scottsdale, AZ (PRWEB) October 8, 2008 -- ... scheduling software, continues to expand its soft...n most "software as a service" providers...
(Date:10/8/2008)... Juva Skin & Laser Center is well e...kin treatments in New York City. The facility is l...e, one of the latest skin resurfacing treatments t...e laser equipment. , New ...urgery and laser treatment industry is in the mids...
Breaking Medicine News(10 mins):Health News:HIV Test Kit Markets a New Development in the War Against the AIDS Virus, an Easy Home HIV Testing Device 2Health News:DIA 6th Canadian Annual Meeting Benefit and Risk Management: An Evolution in Progress 2Health News:Appointment-Plus Continues Innovation With Technical Support Program 2Health News:Upscale New York City Skin Care Center Juva Offering FDA Approved Fraxel re:fine System 2
...n therapy with the new biologic drug adalimumab an...es more effective for people with long-standing rh...gement // with methotrexate alone. It has been fou...ents who fail to respond to standard treatment. A...
... Duke Univ. has shown that the surgical outcome of...n non-diabetics. The results were published Aug. 1...// In the largest analysis of its kind, Duke Univ... found that patients with diabetes who require sur...
...s had said that short-acting Beta-agonist (SABA) p...or asthma morbidity of steroid and non-steroid use...Illinois Medicaid, with a diagnosis of asthma from...esearchers from Chicago, IL, obtained the claims f...
...cer does not discriminate between rich and poor, i...ebrities have succumbed to it and some have fought...mous// actresses and personalities who have suffer...ton-John -Actress and SingerShirley Temple Black -...
Other Medicine News:Health News:Ankle Fracture Surgery – Diabetics fare worse than non-diabetics 2Health News:Ankle Fracture Surgery – Diabetics fare worse than non-diabetics 3
(Date:10/7/2008)...lts of FLEXX Trial Presented at the Osteoarthritis...ess, PARSIPPANY, N.J., Oct. 7 /- Fer...ts from the FLEXX Trial of Osteoarthritis of the,K...te), a highly pure,non-avian high molecular weight...is superior to intra-articular saline (IA-saline) ...
(Date:10/7/2008)... COLLINS, Colo., Oct. 7 /- A study pu... embryonic stem cell self-renewal,reported that I...ecombinant,human serum albumin) was an effective r...ure., The article entitled, "The ground state of ...researchers used Cellastim as a recombinant,albumi...
(Date:10/7/2008)...ent, Prospective Randomized Placebo-Controlled Pha...nt Improved Overall Survival., MOUNTAIN VIEW, Cal...eutics has now evaluated the mature Phase II data ...date PROSTVAC(TM) that had been,obtained as part o...al,Cancer Institute (NCI) in the US., The results...
(Date:10/6/2008)...O and CHIPPENHAM, England, October 7 /PRNewswire-F... Mothers Index: 4565) and Vectura,Group plc ("Vect...studies,evaluating the efficacy, safety and tolera...of the European Respiratory Society (ERS) in Berli...rronium bromide), a novel,inhaled long-acting musc...
Breaking Medicine Technology:Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5North Americas northernmost lake affected by global warming 571 1North Americas northernmost lake affected by global warming 571 2TIGroup Names Dennis M Smith as Chief Financial Officer 2083 1TIGroup Names Dennis M Smith as Chief Financial Officer 2083 2TIGroup Names Dennis M Smith as Chief Financial Officer 2083 3TIGroup Names Dennis M Smith as Chief Financial Officer 2083 4Agendia Joins the Personalized Medicine Coalition 28PMC 29 852 1Agendia Joins the Personalized Medicine Coalition 28PMC 29 852 2Beaumont Technology Usability Center To Offer Training For Medical Technology Companies 847 1Beaumont Technology Usability Center To Offer Training For Medical Technology Companies 847 2
...lood Glucose,Control and Progressive Weight Loss -... Amylin,Pharmaceuticals, Inc. and Eli Lilly and Co...owed BYETTA(R) (exenatide) injection,sustained imp...ight,loss through three and a half years of therap...vements in cardiovascular risk,factors in people w...
...2007--Gilead,Sciences, Inc. (Nasdaq:GILD) today an... evaluating the company,s once-daily,anti-HIV drug...ovir,DF) 300 mg as a potential treatment for chron...ary efficacy endpoint. The data show,that Viread i...al,drug Hepsera(R) (adefovir dipivoxil) among pati...
Other Medicine Technology:Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 2Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 3Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 4Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 5Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 6Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6
...ydroepiandrosterone sulfate (DHEA-S) is the sulfat...and by enzymatic conversion of DHEA in adrenal and...d secreted by the adrenal cortex, and is a precurs...A possesses relatively weak androgenic activity, w...
EL-RF-IgM is high sensitivity quantitative rheumatoid factor IgM.
The Diamedix immunosimplicity® Is- Rheumatoid Factor Test Kit is an EIA procedure intended for the quantitation of IgM antibodies to IgG antigen. The results are reported in IU/mL, traceable to t
The SYNCHRON CX4 Delta Specialty / Drug Clinical System is a random access analyzer that can consolidate Drugs of Abuse, TDM's and other specialty testing, such as thyroid, HbA1c and lipids in one co
Medicine Products: